West Virginia University
Morgantown, West Virginia, 26506, United States
NCT Number: NCT03297658
This is a single site, randomized, blinded, sham controlled, parallel group study to identify whether electro-acupuncture (EA) is a beneficial anesthesia adjunct in children undergoing procedures on their congenital heart defects (CHD).
Looking for future studies?
Notify MeUp to 18 year
All sexes
Interventional
Not applicable
Morgantown, West Virginia, 26506, United States
This investigation is a single site, randomized, blinded, sham controlled, parallel group study to identify whether EA is a beneficial anesthesia adjunct in children undergoing procedures on their congenital heart defects.
Study subjects age's birth to eighteen years, undergoing cardiac surgery for their congenital heart lesions will be considered for entrance into the study. The randomized subjects will receive either EA or sham during their surgery for CHD. Subjects are expected to remain in the hospital 48 hours post procedure. Standard of care blood samples will be obtained pre-operative and post-operative. The only study specific blood sample will be Troponin I levels which will be obtained before surgery begins after the IV lines have been placed, and 6 hours after bypass. Urine samples will be obtained before surgery after placement of the foley catheter and every 6 hours post bypass aortic cross clamp removal for 48 hours while the foley catheter is still in place.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Additionally, patients with coarctation of the aorta for repair will be considered as a separate group and eligible for enrollment.
Exclusion criteria
stimulation of acupuncture points related to congenital heart surgery for comfort heart and renal health
Micro electrodes will be placed but there will be no stimulation
Time frame: baseline and 6 hours after weaning from cardiopulmonary bypass
Troponin level Change from baseline. Troponin lab levels will be measured as a marker of myocardial injury. Children undergoing procedures for their congenital heart disease will have their troponin levels prior to the procedure and 6 hours after weaning from bypass. This study will look at differences between pre and post troponin values in the two groups.
Time frame: every 2 hours for 48 hours after arrival in Pediatric Intensive Care Unit (PICU)
Subjects less than 2 month will have their pain assessed every 2 hours for 48 hours using the Neonatal Infant Pain Scale (NIPS).Pain in children 2 months to 7 years or those that are unable to communicate their pain will have their pain evaluated every 2 hours for 48 hours using the Face, Legs, Cry, Consolability Scale (FLACC). Scale range 0-10. Children older than 10 will have their pain evaluated every 2 hours for 48 hours using a Visual analogue scale (0-10).
Time frame: baseline and 6,12,24, and 48 hours after weaning from Cardiopulmonary bypass
Acute Kidney Injury (AKI) classification will be assessed using the AKIN classification system. This system uses Serum Creatinine and/or Urine output to come up with a staging of 1-3. Patients will be stage at 6, 12, 24, and 48 hours after bypass.
West Virginia University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01208792
Acquired Immunodeficiency Syndrome, Arthritis
Clamart, France
View Trial DetailsNCT04619745
Cardiovascular Abnormalities, Cardiovascular Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT03110861
Cardiovascular Abnormalities, Cardiovascular Diseases
Seoul, Haehak-ro Jongno-gu, South Korea
View Trial DetailsNCT06715137
Cardiovascular Abnormalities, Cardiovascular Diseases
Edegem, Antwerp, Belgium
View Trial Details